1,001 results on '"Henter, Jan‐Inge"'
Search Results
2. Etoposide Therapy of Cytokine Storm Syndromes
3. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
4. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
5. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
6. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival
7. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
8. Seasonality of birth month in patients diagnosed with Langerhans cell histiocytosis (LCH)
9. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
10. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis
11. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
12. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study
13. Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity
14. High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis
15. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
16. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
17. Etoposide Therapy of Cytokine Storm Syndromes
18. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults
19. Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients
20. Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
21. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
22. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
23. Molecular genetics of primary hemophagocytic lymphohistiocytosis among Polish patients
24. Survival in primary hemophagocytic lymphohistiocytosis 2016-2021: etoposide is better than its reputation
25. Treatment of Newly Diagnosed HLH and Refractory Disease
26. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society
27. Clinical and laboratory signs of haemophagocytic lymphohistiocytosis associated with pandemic influenza A(H1N1) infection in patients needing extracorporeal membrane oxygenation: A retrospective observational study
28. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study
29. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
30. With me or against me: Tumor suppressor and drug resistance activities of SAMHD1
31. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
32. Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
33. Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy
34. Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
35. T cell exocytosis testing provides superior sensitivity for the diagnosis of familial HLH
36. The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis
37. The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis
38. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
39. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children
40. The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis
41. HYPERINFLAMMATION IN CRITICALLY ILL PATIENTS IN INTENSIVE CARE
42. Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
43. Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells
44. Cancer risk in relatives of patients with a primary disorder of lymphocyte cytotoxicity: a retrospective cohort study
45. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
46. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
47. Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology
48. Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients
49. Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity
50. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.